Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Enjeti · SciRah

Researcher profile · Semantic Scholar

A. Enjeti

Share profile

A. Enjeti — researcher profile on SciRah

h-index: 28
Works: 148
Citations: 2,642

Most-cited papers

Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II Study
A. Wei, S. Strickland, Jing-Zhou Hou, W. Fiedler +16 more
2019Journal of Clinical Oncology596 citations Open access
Semantic Scholar
Standardization of extracellular vesicle measurements by flow cytometry through vesicle diameter approximation
E. van der Pol, A. Sturk, T. van Leeuwen, R. Nieuwland +38 more
2018Journal of Thrombosis and Haemostasis168 citations Open access
Semantic Scholar
NETosis and thrombosis in vaccine-induced immune thrombotic thrombocytopenia
H. Leung, J. Perdomo, Z. Ahmadi, S. Zheng +5 more
2021Nature Communications76 citations Open access
Semantic Scholar
Magrolimab plus azacitidine vs physician’s choice for untreated TP53-mutated acute myeloid leukemia: the ENHANCE-2 study
J. Zeidner, D. Sallman, Christian Récher, Naval G. Daver +18 more
2025Blood74 citations Open access
Semantic Scholar
Clinical care of pregnant and postpartum women with COVID‐19: Living recommendations from the National COVID‐19 Clinical Evidence Taskforce
Joshua P. Vogel, B. Tendal, M. Giles, C. Whitehead +205 more
2020Australian and New Zealand journal of obstetrics and gynaecology44 citations Open access
Semantic Scholar
Clinical use of SNP-microarrays for the detection of genome-wide changes in haematological malignancies.
Nadine K. Berry, R. Scott, P. Rowlings, A. Enjeti
2019Critical reviews in oncology/hematology40 citations Open access
Semantic Scholar
Venetoclax with Low-Dose Cytarabine Induces Rapid, Deep, and Durable Responses in Previously Untreated Older Adults with AML Ineligible for Intensive Chemotherapy
A. Wei, S. Strickland, Jing-Zhou Hou, W. Fiedler +10 more
2018Blood38 citations Open access
Semantic Scholar
Quantitative phosphoproteomics uncovers synergy between DNA-PK and FLT3 inhibitors in acute myeloid leukaemia
H. Murray, A. Enjeti, R. Kahl, H. Flanagan +13 more
2020Leukemia35 citations Open access
Semantic Scholar
Consensus guidelines for the management of adult immune thrombocytopenia in Australia and New Zealand
P. Choi, E. Merriman, Ashwini Bennett, A. Enjeti +4 more
2021Medical Journal of Australia34 citations Open access
Semantic Scholar
Risk-benefit analysis of the AstraZeneca COVID-19 vaccine in Australia using a Bayesian network modelling framework
C. Lau, H. Mayfield, J. Sinclair, Serena Brown +6 more
2021medRxiv34 citations Open access
Semantic Scholar
Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML: a randomized, placebo-controlled study by the ALLG
S. Loo, A. Roberts, Natasha S. Anstee, G. Kennedy +32 more
2023Blood30 citations Open access
Semantic Scholar
A multi-center randomized controlled trial to reduce unmet needs, depression, and anxiety among hematological cancer patients and their support persons
W. Stevenson, Jamie Bryant, Rochelle Watson, R. Sanson-Fisher +10 more
2019Journal of psychosocial oncology30 citations Open access
Semantic Scholar
Diagnosis and management of heparin‐induced thrombocytopenia: a consensus statement from the Thrombosis and Haemostasis Society of Australia and New Zealand HIT Writing Group
J. Joseph, D. Rabbolini, A. Enjeti, E. Favaloro +6 more
2019Medical Journal of Australia29 citations
Semantic Scholar
Real-world treatment patterns and clinical outcomes in patients with AML unfit for first-line intensive chemotherapy*
T. Miyamoto, D. Sanford, C. Tomuleasa, Hui-Hua Hsiao +12 more
2022Leukemia and Lymphoma28 citations Open access
Semantic Scholar
Blockade of ROS production inhibits oncogenic signaling in acute myeloid leukemia and amplifies response to precision therapies
Zacary P. Germon, Jonathan R. Sillar, Abdul Mannan, Ryan J. Duchatel +28 more
2023Science Signaling21 citations Open access
Semantic Scholar
Unravelling the Epigenome of Myelodysplastic Syndrome: Diagnosis, Prognosis, and Response to Therapy
Danielle R. Bond, Heather J. Lee, A. Enjeti
2020Cancers21 citations Open access
Semantic Scholar
Clinical response to azacitidine in MDS is associated with distinct DNA methylation changes in HSPCs
J. Thoms, Feng Yan, Henry R. Hampton, S. Davidson +52 more
2025Nature Communications20 citations Open access
Semantic Scholar
scTEM-seq: Single-cell analysis of transposable element methylation to link global epigenetic heterogeneity with transcriptional programs
Kooper V Hunt, S. Burnard, E. Roper, Danielle R. Bond +4 more
2022Scientific Reports19 citations Open access
Semantic Scholar
Results of a Phase 2, Randomized, Double-Blind Study of Sorafenib Versus Placebo in Combination with Intensive Chemotherapy in Previously Untreated Patients with FLT3-ITD Acute Myeloid Leukemia (ALLG AMLM16)
A. Wei, G. Kennedy, K. Morris, A. Grigg +30 more
2020Blood19 citations Open access
Semantic Scholar
Shwachman–Bodian–Diamond syndrome (SBDS) protein is a direct inhibitor of protein phosphatase 2A (PP2A) activity and overexpressed in acute myeloid leukaemia
Matthew D. Dun, Abdul Mannan, C. Rigby, Stephen M Butler +22 more
2020Leukemia17 citations Open access
Semantic Scholar
COVID‐19 vaccination in haematology patients: an Australian and New Zealand consensus position statement
G. McCaughan, Pietro R. Di Ciaccio, M. Ananda-Rajah, N. Gilroy +31 more
2021Internal medicine journal (Print)15 citations Open access
Semantic Scholar
Crosstalk between DNA methylation and hypoxia in acute myeloid leukaemia
Sam Humphries, Danielle R. Bond, Zacary P. Germon, S. Keely +3 more
2023Clinical Epigenetics13 citations Open access
Semantic Scholar
Immune thrombocytopenia following vaccination during the COVID-19 pandemic
P. Y. Choi, Danny Hsu, Huyen Tran, Chee-Wee Tan +6 more
2021Haematologica12 citations Open access
Semantic Scholar
Targeting Apoptotic Pathways in Acute Myeloid Leukaemia
Jonathan R. Sillar, A. Enjeti
2019Cancers12 citations Open access
Semantic Scholar
White blood cell evaluation in haematological malignancies using a web‐based digital microscopy platform
Karan Makhija, L. Lincz, Khaled Attalla, F. Scorgie +2 more
2021International Journal of Laboratory Hematology11 citations
Semantic Scholar
A Phase II Randomized Trial Comparing Low-Dose Cytarabine and Venetoclax +/- Midostaurin in Non-Adverse Cytogenetic Risk Acute Myeloid Leukemia: The ALLG AMLM25 Intervene Trial
Chong Chyn Chua, Blake Hsu, A. Enjeti, A. Bajel +18 more
2024Blood10 citations
Semantic Scholar
A comparative evaluation of three consecutive artificial intelligence algorithms released by Techcyte for identification of blasts and white blood cells in abnormal peripheral blood films
L. Lincz, Karan Makhija, Khaled Attalla, F. Scorgie +2 more
2023International Journal of Laboratory Hematology10 citations Open access
Semantic Scholar
Healthcare resource utilization trends in patients with acute myeloid leukemia ineligible for intensive chemotherapy receiving first‐line systemic treatment or best supportive care: A multicenter international study
T. Ito, D. Sanford, C. Tomuleasa, Hui-Hua Hsiao +13 more
2022European Journal of Haematology10 citations Open access
Semantic Scholar
Efficacy of Ibrutinib, Rituximab and Mini-CHOP in Very Elderly Patients with Newly Diagnosed Diffuse Large B Cell Lymphoma: Primary Analysis of the Australasian Leukaemia & Lymphoma Group NHL29 Study
E. Verner, A. Johnston, N. Pati, E. Hawkes +14 more
2021Blood10 citations Open access
Semantic Scholar
Single-cell epigenomics in cancer: charting a course to clinical impact.
Danielle R. Bond, Kumar Uddipto, A. Enjeti, Heather J. Lee
2020Epigenomics10 citations Open access
Semantic Scholar
Revumenib As Pre-Emptive Therapy for Measurable Residual Disease in NPM1 mutated or KMT2A-rearranged Acute Myeloid Leukemia: A Domain of the Multi-Arm ALLG AMLM26 Intercept Platform Trial
S. Loo, Harry J. Iland, I. Tiong, David Westerman +26 more
2024Blood9 citations Open access
Semantic Scholar
Validating lactate dehydrogenase (LDH) as a component of the PLASMIC predictive tool (PLASMIC-LDH)
C. Liam, J. Tiao, Y. Y. Yap, Yi-Lin Lee +18 more
2023Blood Research8 citations Open access
Semantic Scholar
Circulating microvesicles are less procoagulant and carry different miRNA cargo in myelodysplasia.
A. Enjeti, A. Ariyarajah, Angel D'Crus, C. Riveros +2 more
2019Blood Cells, Molecules & Diseases8 citations Open access
Semantic Scholar
Intensive care unit outcomes in patients with hematological malignancy
J. Rawson, F. Fagan, Georgin Claire Burrough, Helen M. Tang +3 more
2020Blood Science7 citations Open access
Semantic Scholar
The effects of tetrahydrocurcumin compared to curcuminoids on human platelet aggregation and blood coagulation in vitro.
K. Chapman, F. Scorgie, A. Ariyarajah, Eleanor Stephens +2 more
2019Thrombosis Research7 citations
Semantic Scholar
How comparable are patient outcomes in the “real-world” with populations studied in pivotal AML trials?
I. Tiong, M. Wall, A. Bajel, Akash Kalro +34 more
2024Blood Cancer Journal6 citations Open access
Semantic Scholar
Panel-based gene testing in myelodysplastic/myeloproliferative neoplasm- overlap syndromes: Australasian Leukaemia and Lymphoma Group (ALLG) consensus statement.
A. Enjeti, Rishu Agarwal, P. Blombery, L. Chee +10 more
2022Pathology (Sydney)6 citations Open access
Semantic Scholar
Prolonged administration of low-dose cytarabine and thioguanine in elderly patients with acute myeloid leukaemia (AML) achieves high complete remission rates and prolonged survival
C. Arthur, A. Jeffrey, E. Yip, Vicki Katsioulas +9 more
2019Leukemia and Lymphoma6 citations
Semantic Scholar
Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients with Myelodysplastic Syndromes/Neoplasms (MDS): An Analysis from the International Consortium for MDS (icMDS) Validate Database
Benjamin Rolles, J. Bewersdorf, Tariq Kewan, O. Bláha +54 more
2024Blood5 citations
Semantic Scholar
Real‐world study of the use of azacitidine in myelodysplasia in Australia
A. Enjeti, A. Ashraf, Vincent Caillet, Arif Alam +4 more
2024eJHaem5 citations Open access
Semantic Scholar
High Deliverability of a Midostaurin Triplet Regimen Incorporating Venetoclax and Low Dose Cytarabine in Non-Adverse Cytogenetic Risk Acute Myeloid Leukaemia: A Sub-Analysis of the Australasian Leukaemia Lymphoma Group (ALLG) Intervene Study
Chong Chyn Chua, Natasha S. Anstee, A. Enjeti, D. Hiwase +15 more
2022Blood5 citations Open access
Semantic Scholar
Immune thrombocytopenia and COVID-19 vaccination: Outcomes and comparisons to prepandemic patients
P. Y. Choi, D. Hsu, Huyen A. Tran, Chee-Wee Tan +10 more
2022Research and Practice in Thrombosis and Haemostasis5 citations Open access
Semantic Scholar
A Phase-Ib/II Clinical Evaluation of Ponatinib in Combination with Azacitidine in FLT3-ITD and CBL-Mutant Acute Myeloid Leukemia (PON-AZA study)
D. Kipp, S. Loo, A. Perkins, S. Lane +5 more
2021Blood5 citations
Semantic Scholar
Enrichment of atypical hyperdiploidy and IKZF1 deletions detected by SNP-microarray in high-risk Australian AIEOP-BFM B-cell acute lymphoblastic leukaemia cohort.
Nadine K. Berry, R. Scott, R. Sutton, T. Law +5 more
2020Cancer Genetics5 citations Open access
Semantic Scholar
Transfusion‐associated circulatory overload in ambulatory patients
Jock D Simpson, A. Hopkins, A. Amil, Bryony Ross +1 more
2019Vox Sanguinis5 citations
Semantic Scholar
Risk stratification of low-dose cytarabine and venetoclax in patients with AML ineligible for intensive chemotherapy
Andrew H. Wei, P. Panayiotidis, P. Montesinos, K. Laribi +25 more
2025Blood Advances4 citations Open access
Semantic Scholar
Ibrutinib plus rituximab and mini-CHOP in older patients with newly diagnosed DLBCL: a phase 2 ALLG study
E. Verner, A. Johnston, N. Pati, E. Hawkes +15 more
2024Blood Advances4 citations Open access
Semantic Scholar
High Expression of ENO1 and Low Levels of Circulating Anti-ENO1 Autoantibodies in Patients with Myelodysplastic Neoplasms and Acute Myeloid Leukaemia
L. Lincz, Danielle Z Theron, Daniel L Barry, F. Scorgie +4 more
2024Cancers4 citations Open access
Semantic Scholar
Combination of Venetoclax and Azacitidine in Patients with Treatment-Naive, High-Risk Myelodysplastic Syndromes with Responses Leading to Stem Cell Transplantation
G. Garcia-Manero, O. Odenike, Shaun A. Fleming, G. Roboz +12 more
2023Blood4 citations Open access
Semantic Scholar
Genomic investigation of inherited thrombotic microangiopathy—aHUS and TTP
A. Enjeti, Theo Malmanche, K. Chapman, A. Ziolkowski
2020International Journal of Laboratory Hematology4 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Wei×7
Invite
A. Wei — researcher profile on SciRah
I. Tiong×7
Invite
I. Tiong — researcher profile on SciRah
D. Hiwase×7
Invite
D. Hiwase — researcher profile on SciRah
J. Curnow×6
Invite
J. Curnow — researcher profile on SciRah

×6

Invite

P. Marlton — researcher profile on SciRah

Invite

A. Bajel — researcher profile on SciRah

Invite

G. Roboz — researcher profile on SciRah

Jonathan R. Sillar×5

Invite

Jonathan R. Sillar — researcher profile on SciRah

Matthew D. Dun×5

Invite

Matthew D. Dun — researcher profile on SciRah

Natasha S. Anstee×5

Invite

Natasha S. Anstee — researcher profile on SciRah

Invite

E. Verner — researcher profile on SciRah

Invite

L. Lincz — researcher profile on SciRah